|
|
|
Insider
Information: |
Lewis Joel |
Relationship: |
|
City: |
Norcross |
State: |
GA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
897,012 |
|
Indirect Shares
|
2,000 |
|
|
Direct
Value |
$2,735,887 |
|
|
Indirect Value
|
$6,100 |
|
|
Total
Shares |
899,012 |
|
|
Total
Value |
$2,741,987 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
1
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
13.4%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Galectin Therapeutics Inc |
GALT |
|
2024-04-24 |
897,012 |
2024-04-24 |
2,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
93 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-03-15 |
4 |
A |
$2.50 |
$16,668 |
D/D |
6,667 |
194,324 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-02-15 |
4 |
A |
$2.49 |
$16,666 |
D/D |
6,693 |
180,217 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-12-15 |
4 |
A |
$2.25 |
$16,666 |
D/D |
7,407 |
291,565 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2020-12-31 |
4 |
A |
$2.24 |
$16,666 |
D/D |
7,440 |
157,411 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-02-26 |
4 |
A |
$2.24 |
$16,666 |
D/D |
7,440 |
187,657 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-04-15 |
4 |
A |
$2.23 |
$16,667 |
D/D |
7,474 |
209,478 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-01-15 |
4 |
A |
$2.19 |
$16,666 |
D/D |
7,610 |
165,021 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-03-31 |
4 |
A |
$2.17 |
$16,666 |
D/D |
7,680 |
202,004 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2022-07-29 |
4/A |
A |
$2.26 |
$17,499 |
D/D |
7,743 |
552,139 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
Director |
|
2020-02-09 |
4 |
OE |
$2.39 |
$19,120 |
D/D |
8,000 |
107,104 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2022-08-15 |
4 |
A |
$2.18 |
$17,501 |
D/D |
8,028 |
587,194 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-12-31 |
4 |
A |
$2.07 |
$16,668 |
D/D |
8,052 |
299,617 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2022-01-14 |
4 |
A |
$2.02 |
$16,667 |
D/D |
8,251 |
307,868 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2022-02-15 |
4 |
A |
$2.07 |
$17,500 |
D/D |
8,454 |
428,585 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2021-01-29 |
4 |
A |
$1.96 |
$16,666 |
D/D |
8,503 |
173,524 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2022-08-31 |
4 |
A |
$1.90 |
$17,501 |
D/D |
9,211 |
596,405 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2023-02-28 |
4 |
A |
$2.07 |
$19,268 |
D/D |
9,308 |
895,828 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2022-02-28 |
4 |
A |
$1.87 |
$17,499 |
D/D |
9,358 |
438 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2023-10-31 |
4 |
A |
$2.04 |
$19,266 |
D/D |
9,444 |
998,469 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2023-04-14 |
4 |
A |
$2.01 |
$19,266 |
D/D |
9,585 |
849,199 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2023-10-13 |
4/A |
A |
$2.01 |
$19,266 |
D/D |
9,585 |
989,025 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2022-09-15 |
4 |
A |
$1.79 |
$17,501 |
D/D |
9,777 |
606,182 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2023-11-30 |
4 |
A |
$1.95 |
$19,266 |
D/D |
9,880 |
1,018,652 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2023-09-29 |
4 |
A |
$1.92 |
$19,267 |
D/D |
10,035 |
979,440 |
0 |
- |
|
GALT |
Galectin Therapeutics Inc |
President and CEO |
|
2023-10-13 |
4 |
A |
$2.01 |
$20,170 |
D/D |
10,035 |
989,025 |
0 |
- |
|
93 Records found
|
|
Page 2 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|